Categories: Health

Cannabix Technologies Annual General and Special Meeting Results

 | Source: Cannabix Technologies Inc.

VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on July 24, 2025 in Vancouver. Resolutions passed at the meeting included the appointment of SHIM and Associates LLP as auditors for the ensuing year, and the election of five directors: Dr. Raj Attariwala, Dr. Phillip Olla, Ravinder Mlait, Bryan Loree, and William Corl.

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For further information, contact the Company at info@cannabixtechnologies.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

GlobeNews Wire

Recent Posts

OMAN’S MUSCAT STOCK EXCHANGE TRADING VALUE UP FIVEFOLD TO USD 8.45 BILLION

MUSCAT, Oman, Nov. 5, 2025 /PRNewswire/ -- Oman's Muscat Stock Exchange (MSX) has recorded its strongest…

24 minutes ago

Wahed and KraneShares Announce the Launch of KWIN: A Shariah-Compliant Alternative Income ETF for Faith-Aligned Investors

NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Wahed, a global leader in Shariah-compliant digital investing,…

24 minutes ago

Litecoin Creator Charlie Lee Joins SilentSwap as Strategic Advisor to Advance Privacy Infrastructure for Digital Assets

Cryptocurrency Pioneer Brings Deep Technical Expertise and Vision for Financial Privacy to Next-Generation Cross-Chain Platform…

2 hours ago

IBM and Agassi Sports Entertainment Announce AI-Powered Platform to Advance Global Racquet Sports

Partnering to deliver a digital platform with AI-powered video coaching, premium content, and commercial experiences…

2 hours ago

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth

POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Curonix LLC (“Curonix” or the “Company”),…

5 hours ago

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44%…

5 hours ago